AU510809B2 - Method for combating virus infections - Google Patents

Method for combating virus infections

Info

Publication number
AU510809B2
AU510809B2 AU26505/77A AU2650577A AU510809B2 AU 510809 B2 AU510809 B2 AU 510809B2 AU 26505/77 A AU26505/77 A AU 26505/77A AU 2650577 A AU2650577 A AU 2650577A AU 510809 B2 AU510809 B2 AU 510809B2
Authority
AU
Australia
Prior art keywords
treatment
acid
pharmaceutical preparation
phosphonoformic acid
physiologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired, expires
Application number
AU26505/77A
Other languages
English (en)
Other versions
AU2650577A (en
Inventor
B. F. H. Bergstrand A. J. E. Misiorny A. Steiling G. B. and Stride SA. A Eriksson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20328354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU510809(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of AU2650577A publication Critical patent/AU2650577A/en
Application granted granted Critical
Publication of AU510809B2 publication Critical patent/AU510809B2/en
Adjusted expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU26505/77A 1976-07-01 1977-06-27 Method for combating virus infections Expired AU510809B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7607496A SE7607496L (sv) 1976-07-01 1976-07-01 Sett for bekempning av virusinfektioner
SESE7,607,49 1976-07-01

Publications (2)

Publication Number Publication Date
AU2650577A AU2650577A (en) 1979-01-04
AU510809B2 true AU510809B2 (en) 1980-07-17

Family

ID=20328354

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26505/77A Expired AU510809B2 (en) 1976-07-01 1977-06-27 Method for combating virus infections

Country Status (22)

Country Link
US (4) US4215113A (cg-RX-API-DMAC10.html)
JP (1) JPS536428A (cg-RX-API-DMAC10.html)
AT (1) AT369014B (cg-RX-API-DMAC10.html)
AU (1) AU510809B2 (cg-RX-API-DMAC10.html)
BE (1) BE856355A (cg-RX-API-DMAC10.html)
BG (1) BG60834B2 (cg-RX-API-DMAC10.html)
CA (1) CA1077848A (cg-RX-API-DMAC10.html)
CH (1) CH641471A5 (cg-RX-API-DMAC10.html)
DE (1) DE2728685C2 (cg-RX-API-DMAC10.html)
DK (1) DK288877A (cg-RX-API-DMAC10.html)
FI (1) FI772030A7 (cg-RX-API-DMAC10.html)
FR (1) FR2356424A1 (cg-RX-API-DMAC10.html)
GB (1) GB1585615A (cg-RX-API-DMAC10.html)
HK (1) HK28984A (cg-RX-API-DMAC10.html)
IE (1) IE45753B1 (cg-RX-API-DMAC10.html)
LU (2) LU77666A1 (cg-RX-API-DMAC10.html)
MX (1) MX9203635A (cg-RX-API-DMAC10.html)
MY (1) MY8500125A (cg-RX-API-DMAC10.html)
NL (2) NL180068C (cg-RX-API-DMAC10.html)
NO (1) NO772299L (cg-RX-API-DMAC10.html)
SE (1) SE7607496L (cg-RX-API-DMAC10.html)
SG (1) SG80383G (cg-RX-API-DMAC10.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140049A (en) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid
DK564378A (da) * 1977-12-22 1979-06-23 Astra Laekemedel Ab Fremgangsmaade til fremstilling af amidderivater til bekaempelse af virusinfektioner
DE2926799A1 (de) * 1979-07-03 1981-01-15 Bayer Ag Phosphonoameisensaeurehydrazide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2941384A1 (de) * 1979-10-12 1981-04-23 Bayer Ag, 5090 Leverkusen Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
WO1983002723A1 (en) * 1982-02-12 1983-08-18 Smith, Kendall, O. Anti-viral compositions
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
JPH0761814B2 (ja) * 1984-09-10 1995-07-05 三菱化学株式会社 搬送装置
JPS61217434A (ja) * 1985-03-20 1986-09-27 Mitsubishi Chem Ind Ltd 搬送用装置
JPS6194925A (ja) * 1984-10-12 1986-05-13 Mitsubishi Chem Ind Ltd 搬送用装置
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4880619A (en) * 1985-03-11 1989-11-14 Colgate-Palmolive Company Anticalculus oral composition
US4590064A (en) * 1985-03-11 1986-05-20 Colgate-Palmolive Company Anticalculus oral composition
GB8512330D0 (en) * 1985-05-15 1985-06-19 Wellcome Found Antiviral compounds
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
WO1987002246A1 (en) * 1985-10-21 1987-04-23 William Sergio Method for reducing the risk or probability of infection from the aids virus (htlv-iii/lav/arv)
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US6110901A (en) * 1990-07-03 2000-08-29 American Cyanamid Company Method for treating RNA viral infections by using RNA chain terminators
SE9403861D0 (sv) * 1994-11-09 1994-11-09 Astra Ab Novel medicinal use
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
WO1996039148A1 (en) * 1995-06-06 1996-12-12 University Of Southern California Methods and compositions for inhibiting cytomegalovirus replication
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
RU2116790C1 (ru) * 1997-07-02 1998-08-10 Закрытое акционерное общество "Рефарм" Наружное противоинфекционное средство "рефарм"
RU2124881C1 (ru) * 1997-11-26 1999-01-20 Матковская Татьяна Александровна Наружное лечебно-косметическое средство
FI980216A0 (fi) * 1998-01-30 1998-01-30 Bene Pharma Oy Medicin foer behandling av vaorfor
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
DE19940748A1 (de) * 1999-08-27 2001-03-01 Hugo Seinfeld Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide
US20040131622A1 (en) * 2002-07-15 2004-07-08 Board Of Regents Combinations and kits for treating viral infections using immunoconjugates to aminophospholipids
US7611704B2 (en) * 2002-07-15 2009-11-03 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7455833B2 (en) * 2002-07-15 2008-11-25 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7906115B2 (en) 2002-07-15 2011-03-15 Thorpe Philip E Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7790159B2 (en) * 2002-07-15 2010-09-07 Board Of Regents, The University Of Texas System Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
EP1603542A1 (en) * 2003-03-14 2005-12-14 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
US7424812B2 (en) 2003-05-16 2008-09-16 Stanton Concepts Inc. Multiple function lock
US20090214676A1 (en) * 2005-04-30 2009-08-27 Tissuetech, Inc. Method for treating ocular demodex
US20080045482A1 (en) * 2006-01-27 2008-02-21 Adventrx Pharmaceuticals, Inc. Compositions and methods for the treatment of viral infections
US8128968B2 (en) * 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
WO2009114153A1 (en) * 2008-03-12 2009-09-17 Nektar Therapeutics Oligomer-foscarnet conjugates
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
WO2022153334A1 (en) * 2021-01-15 2022-07-21 Jubilant Generics Ltd Transmucosal dosage forms of foscarnet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
US3836650A (en) * 1971-02-25 1974-09-17 Abbott Lab Method for combating marek's disease in poultry
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate

Also Published As

Publication number Publication date
AU2650577A (en) 1979-01-04
GB1585615A (en) 1981-03-11
SE7607496L (sv) 1978-01-02
MY8500125A (en) 1985-12-31
DE2728685A1 (de) 1978-01-12
NL7707235A (nl) 1978-01-03
NO772299L (no) 1978-04-25
US4215113A (en) 1980-07-29
FI772030A7 (cg-RX-API-DMAC10.html) 1978-01-02
NL930053I2 (nl) 1994-01-03
NL930053I1 (nl) 1993-09-01
LU88310I2 (fr) 1994-05-04
US4339445A (en) 1982-07-13
HK28984A (en) 1984-04-06
IE45753L (en) 1978-01-01
SG80383G (en) 1984-08-03
US4665062A (en) 1987-05-12
CH641471A5 (de) 1984-02-29
BE856355A (fr) 1978-01-02
NL180068B (nl) 1986-08-01
CA1077848A (en) 1980-05-20
AT369014B (de) 1982-11-25
DE2728685C2 (de) 1982-09-16
NL180068C (nl) 1987-01-02
DK288877A (da) 1978-01-02
LU77666A1 (cg-RX-API-DMAC10.html) 1977-10-07
FR2356424A1 (fr) 1978-01-27
FR2356424B1 (cg-RX-API-DMAC10.html) 1980-04-18
US4771041A (en) 1988-09-13
JPS562046B2 (cg-RX-API-DMAC10.html) 1981-01-17
MX9203635A (es) 1992-09-01
IE45753B1 (en) 1982-11-17
JPS536428A (en) 1978-01-20
BG60834B2 (bg) 1996-04-30
ATA465477A (de) 1982-04-15

Similar Documents

Publication Publication Date Title
AU2650577A (en) Method for combating virus infections
AU508310B2 (en) Hanger-clip closures for casings
AU505080B2 (en) 2-piperazinyl-6, 7-dimethoxyquinazolines
AU3116977A (en) Polyfluoroallyloxy compounds
AU2162677A (en) Sodium cromoglycate
AU497953B2 (en) Film processing system
AU3191277A (en) Tumour-resolving medicament
AU511533B2 (en) Wellpoint system
AU514900B2 (en) Framing system
AU520755B2 (en) Polyene compounds
AU513950B2 (en) Carbostyril derivatives
AU2195277A (en) Pipeazine derivatives
AU509291B2 (en) N-(1'-allyl 2'-pyrrolidylmethyl1) 2,3-dimethoxy 5-sulfamoylbenzamide derivatives
AU1492676A (en) Photographic reproportioning system
AU2720077A (en) E. g. r. system
AU2144377A (en) Quinoxaline-din-oxide derivatives
AU534421B2 (en) Method
AU2049476A (en) N-aminosulfenyl carbamate compounds
AU506922B2 (en) N-6-chlorunicotinoyl-d, l-homocysteing thiolactonne
AU2818377A (en) Contrast Corrector
AU519252B2 (en) Thiophosphorylguanidines for combating pests
AU517876B2 (en) Prostaglandin-analogous cyclopentane derivatives
AU516512B2 (en) Process for n-butanol
AU511196B2 (en) Improvements insound deadeners
AU510786B2 (en) Racquet for ballgames